TrialFind
Saved trials
Back to results
Completed
Phase 3
Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
NCT00082602
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
View on ClinicalTrials.gov
Official details
Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease — TrialFind